跳至主要内容
临床试验/TCTR20210903002
TCTR20210903002Enrolling By Invitation1 期

A Pharmacokinetic Comparison of Oral Solution and Tablet Formulations of Favipiravir 200 mg in Healthy Thai Volunteers under Fasting Conditions

Chulabhorn Royal Academy0 个研究点目标入组 24 人开始时间: 2021年9月3日最近更新:

试验速览

阶段
1 期
状态
Enrolling By Invitation
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 55 Years(—)
性别
All

入选标准

  • 1. Thai male/female healthy volunteers, 18-55 years of age
  • 2. Normal hematologic, renal and liver function

排除标准

  • 1. Known hypersensitivity to favipiravir, any other similar class of drugs or its components
  • 2. Past medical history of renal and hepatic insufficiency
  • 3. Subject has a history of any illness that, in the opinion of principal investigator or designated physicians, might confound the result of the study or pose an additional risk in administering study drug to the subject.
  • 4. Have history of drug abuse in the last 12 months
  • 5. Female subject is pregnant or breast feeding.
  • 6. Difficult swallowing the study drug
  • 7. Have positive RT-PCR for nasopharyngeal swab

研究者

相似试验